Bioline Rx (BLRX) Free Cash Flow (2009 - 2026)
Bioline Rx (BLRX) free cash flow from Dec 31, 2009 to Mar 31, 2026. The TTM Bioline Rx (BLRX) free cash flow is -$7.84M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Bioline Rx (BLRX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -75.79% |
| 3 Years TTM | -35.41% |
| 5 Years TTM | -19.16% |
| 10 Years TTM | -7.77% |
Annual Free Cash Flow change of Bioline Rx (BLRX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$2.29M | -71.97% |
| 2025 | -$8.17M | -81.40% |
| 2024 | -$44M | +91.71% |
| 2023 | -$23M | -13.74% |
| 2022 | -$27M | +12.21% |
| 2021 | -$24M | +1.54% |
| 2020 | -$23M | +2.51% |
| 2019 | -$23M | -33.91% |
| 2018 | -$34M | +38.81% |
| 2017 | -$25M | +70.14% |
| 2016 | -$15M | -13.74% |
| 2015 | -$17M | +15.21% |
| 2014 | -$15M | -27.96% |
| 2013 | -$20M | +0.30% |
| 2012 | -$20M | +76.43% |
| 2011 | -$12M | -206.48% |
| 2010 | $11M | -150.07% |
| 2009 | -$22M | -25.29% |
| 2008 | -$29M | N/A |
Comparison Bioline Rx (BLRX) five years free cash flow CAGR with competitors
Bioline Rx (BLRX) five years free cash flow CAGR is -19.20%.